Up-regulated NF-κB activity has been detected in various human cancers, potentially inducing the secretion of tumor-promoting cytokines and promoting cell resistance to anti-cancer therapies [2,8,9,10,11,12,13]. The gene discussed is NFKB1; the disease is cancer.